Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of CCM in HF With Higher Ejection Fraction

NCT: NCT05064709 · RECRUITING

NCT IDNCT05064709
StatusRECRUITING
Start Date2022-02-03
Completion2029-02-01
SponsorImpulse Dynamics (INDUSTRY)
First posted
Last updated

Brief Summary

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑